Trial Bolsters Three Drug Combination Treatment as Standard After First Multiple Myeloma Relapse

Published Jun 7, 2019

Trial Bolsters Three Drug Combination Treatment as Standard After First Multiple Myeloma Relapse

A new trial confirms the effectiveness of pomalidomide in treating lenalidomide resistant multiple myeloma

NOW
PLAYING
If You're Over 65, Here's What You Need to Know About CAR T-Cell Therapy
NOW
PLAYING
For Newly Diagnosed Multiple Myeloma Patients-- The New Four Drug Combination Showing Unprecedented Results
NOW
PLAYING
A New Option for Some People With Lung Cancer: How This Immunotherapy/Chemotherapy Combo Can Increase Treatment Success
NOW
PLAYING
Some Melanoma Survivors See Long-Term Side Effects After Immunotherapy, Says New Study
NOW
PLAYING
What's the Link Between Cancer and Vitamin D?
NOW
PLAYING
New Hope for Multiple Myeloma Patients: Study of New CAR T-cell Therapy Shows The Best Result In The History of The Disease

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.